The Price of Success-The Long-Term Outcomes of Children with Craniopharyngioma-Two Institutions' Experience.
craniopharyngioma
endocrinopathies
long-term complications
pediatric oncology
Journal
Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936
Informations de publication
Date de publication:
24 Jul 2023
24 Jul 2023
Historique:
received:
30
06
2023
revised:
18
07
2023
accepted:
21
07
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
An analysis of patients below 21 years old treated due to craniopharyngioma in the years 1979-2022 was performed with the aim of evaluating the long-term outcome and treatment side-effects. The standard statistical tests were used, and 56 patients with a median age of 11 years were evaluated. Surgery was the primary treatment in 55 patients; however, in only 29 it was the only neurosurgical intervention. Eighteen children were treated with radiotherapy (RTH) in primary treatment. The most common neurosurgical side effects observed were visual and endocrine deficits and obesity, which were diagnosed in 27 (49%), 50 (91%), and 25 (52%) patients, respectively. Complications after RTH were diagnosed in 14 cases (32%). During the median follow-up of 8.4 years (range: 0.4-39.8 years), six patients died and the 5- and 10-year overall survival was 97% and 93%, respectively. Five-year progression-free survival for gross total resection, resection with adjuvant RTH, and non-radical resection alone was 83%, 68%, and 23%, respectively (
Identifiants
pubmed: 37508770
pii: children10071272
doi: 10.3390/children10071272
pmc: PMC10378116
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
J Neurosurg. 2021 Mar 05;135(5):1298-1309
pubmed: 33668037
Klin Padiatr. 2014 May;226(3):161-8
pubmed: 24819386
Pediatr Blood Cancer. 2018 May;65(5):e26936
pubmed: 29286573
Horm Res. 2008;69(4):193-202
pubmed: 18204266
N Engl J Med. 2015 Aug 20;373(8):726-36
pubmed: 26287849
Neuro Oncol. 2022 Dec 1;24(12):2200-2209
pubmed: 35556133
Childs Nerv Syst. 2019 Jan;35(1):169-173
pubmed: 30069716
Eur J Endocrinol. 2015 Dec;173(6):853-62
pubmed: 26392473
Neurosurg Focus. 2016 Dec;41(6):E5
pubmed: 27903113
J Neurooncol. 2022 Jan;156(1):195-204
pubmed: 34846639
Front Oncol. 2022 Nov 30;12:1058329
pubmed: 36530998
J Clin Endocrinol Metab. 2022 Feb 17;107(3):e1020-e1031
pubmed: 34718649
J Endocrinol Invest. 2023 Jun;46(6):1219-1232
pubmed: 36550264
Neuroendocrinology. 2020;110(9-10):753-766
pubmed: 31678973
Pituitary. 2022 Jun;25(3):383-392
pubmed: 35301645
J Neurosurg. 2008 Apr;108(4):715-28
pubmed: 18377251
N Engl J Med. 2010 Aug 26;363(9):809-19
pubmed: 20818844
Eur J Endocrinol. 2017 Jun;176(6):755-767
pubmed: 28325825
Neuro Oncol. 2022 Dec 1;24(12):2210-2220
pubmed: 35481829
Neurosurg Focus. 2016 Dec;41(6):E7
pubmed: 27903116
J Clin Endocrinol Metab. 2019 Dec 1;104(12):5751-5764
pubmed: 31369091
J Neurosurg. 2018 Apr 27;130(4):1299-1303
pubmed: 29701552
J Endocr Soc. 2021 Mar 16;5(5):bvab043
pubmed: 33928205
J Natl Compr Canc Netw. 2020 Dec 02;18(12):1590-1595
pubmed: 33285519
Anticancer Res. 2019 Feb;39(2):803-807
pubmed: 30711960
J Neurosurg. 2018 Oct 26;131(2):526-531
pubmed: 30485192
J Clin Endocrinol Metab. 2017 Mar 01;102(3):1051-1058
pubmed: 28359095
World Neurosurg. 2012 Feb;77(2):329-41
pubmed: 22501020
Radiat Oncol. 2014 Sep 16;9:203
pubmed: 25227427
Neuro Oncol. 2023 Feb 14;25(2):224-233
pubmed: 36124689
Acta Neurochir (Wien). 2021 Feb;163(2):499-509
pubmed: 33078364
J Neurosurg Pediatr. 2023 Feb 17;31(5):453-462
pubmed: 36806176
Pituitary. 2013 Mar;16(1):18-25
pubmed: 22836237
Neurosurg Focus. 2010 Apr;28(4):E5
pubmed: 20367362
Pediatr Blood Cancer. 2020 Aug 13;:e28493
pubmed: 32790146
Front Oncol. 2023 May 05;13:1149428
pubmed: 37213301
J Neurol Surg A Cent Eur Neurosurg. 2018 May;79(3):247-256
pubmed: 29195268
Radiol Oncol. 2019 Oct 25;53(4):388-396
pubmed: 31652121
Neurosurg Focus. 2010 Apr;28(4):E10
pubmed: 20367354
Nat Genet. 2014 Feb;46(2):161-5
pubmed: 24413733
Front Biosci (Landmark Ed). 2022 Apr 20;27(4):136
pubmed: 35468695
Eur J Endocrinol. 2017 Mar;176(3):359-369
pubmed: 28073908
Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):354-61
pubmed: 25052561
J Neurooncol. 2016 Jan;126(2):371-6
pubmed: 26514358
Neurocirugia (Astur : Engl Ed). 2023 Mar-Apr;34(2):67-74
pubmed: 36754754
J Neurosurg. 2007 Jan;106(1 Suppl):3-12
pubmed: 17233305
Horm Res Paediatr. 2010;73(3):175-80
pubmed: 20197669
World Neurosurg. 2020 Oct;142:582-592
pubmed: 32987614
J Neuropathol Exp Neurol. 2017 Feb 1;76(2):126-134
pubmed: 28069929
Int J Radiat Oncol Biol Phys. 2021 Aug 1;110(5):1480-1487
pubmed: 33662460
J Neurol Surg B Skull Base. 2018 Feb;79(1):65-80
pubmed: 29404243
Cancer Radiother. 2022 Feb-Apr;26(1-2):137-146
pubmed: 34953692
Neuro Oncol. 2021 Aug 2;23(8):1231-1251
pubmed: 34185076
Neurol India. 2022 Mar-Apr;70(2):600-605
pubmed: 35532626
Radiother Oncol. 2021 Mar;156:80-94
pubmed: 33309848
Front Med (Lausanne). 2022 Jan 26;8:652005
pubmed: 35155453
Acta Neuropathol Commun. 2016 Feb 29;4:20
pubmed: 26927026
Acta Neurochir (Wien). 2021 Nov;163(11):3201-3207
pubmed: 34518903
J Neurosurg. 2021 Mar 05;135(5):1293-1295
pubmed: 33668034
J Neurosurg. 2008 May;108(5):1043-7
pubmed: 18447729
Pituitary. 2016 Oct;19(5):544-6
pubmed: 26115708
Lancet Oncol. 2023 May;24(5):523-534
pubmed: 37084748
Childs Nerv Syst. 2013 Feb;29(2):231-8
pubmed: 23089933
J Natl Cancer Inst. 2015 Oct 23;108(2):
pubmed: 26498373
J Neurosurg. 1990 Jul;73(1):3-11
pubmed: 2352020
Childs Nerv Syst. 2019 Nov;35(11):2133-2145
pubmed: 31385085
Childs Nerv Syst. 2021 Oct;37(10):3033-3040
pubmed: 34213590